The DOI matches its Crossref record; 97 of the 97 references it cites were found in a registry or an index.
Strategies to Enhance Drug Absorption via Nasal and Pulmonary Routes
Open accessAbstract
New therapeutic agents such as proteins, peptides, and nucleic acid-based agents are being developed every year, making it vital to find a non-invasive route such as nasal or pulmonary for their administration. However, a major concern for some of these newly developed therapeutic agents is their poor absorption. Therefore, absorption enhancers have been investigated to address this major administration problem. This paper describes the basic concepts of transmucosal administration of drugs, and in particular the use of the pulmonary or nasal routes for administration of drugs with poor absorption. Strategies for the exploitation of absorption enhancers for the improvement of pulmonary or nasal administration are discussed, including use of surfactants, cyclodextrins, protease inhibitors, and tight junction modulators, as well as application of carriers such as liposomes and nanoparticles.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Exosomes as drug delivery vehicles for Parkinson’s disease therapy
Haney, M. J., Klyachko, N. L., Zhao, Y., Gupta, R., Plotnikova, E. G., He, Z., Patel, T., Piroyan, A., Sokolsky, M., Kabanov, A. V., et al. (2015) · Journal of Controlled Release · doi:10.1016/j.jconrel.2015.03.033 · Cited by 2,009
Tian, Y., Li, S., Song, J., Ji, T., Zhu, M., Anderson, G. J., Wei, J., & Nie, G. (2014) · Biomaterials · doi:10.1016/j.biomaterials.2013.11.083 · Cited by 1,801
MicroRNAs bind to Toll-like receptors to induce prometastatic inflammatory response
Fabbri, M., Paone, A., Calore, F., Galli, R., Gaudio, E., Santhanam, R., Lovat, F., Fadda, P., Mao, C., Nuovo, G. J., et al. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1209414109 · Cited by 1,434
Zhuang, X., Xiang, X., Grizzle, W., Sun, D., Zhang, S., Axtell, R. C., Ju, S., Mu, J., Zhang, L., Steinman, L., et al. (2011) · Molecular Therapy · doi:10.1038/mt.2011.164 · Cited by 1,356
Extracellular vesicles for drug delivery.
Vader, P., Mol, E. A., Pasterkamp, G., & Schiffelers, R. M. (2016) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2016.02.006 · Cited by 1,319
Engineering exosomes as refined biological nanoplatforms for drug delivery
Luan, X., Sansanaphongpricha, K., Myers, I., Chen, H., Yuan, H., & Sun, D. (2017) · Acta Pharmacologica Sinica · doi:10.1038/aps.2017.12 · Cited by 1,163
Cell Internalization of the Third Helix of the Antennapedia Homeodomain Is Receptor-independent
Derossi, D., Calvet, S., Trembleau, A., Brunissen, A., Chassaing, G., & Prochiantz, A. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.30.18188 · Cited by 1,073
Using exosomes, naturally-equipped nanocarriers, for drug delivery
Batrakova, E. V., & Kim, M. S. (2015) · Journal of Controlled Release · doi:10.1016/j.jconrel.2015.07.030 · Cited by 1,041
Yang, T., Martin, P., Fogarty, B., Brown, A., Schurman, K., Phipps, R., Yin, V. P., Lockman, P., & Bai, S. (2015) · Pharmaceutical Research · doi:10.1007/s11095-014-1593-y · Cited by 975
Nanoparticles for direct nose-to-brain delivery of drugs
Mistry, A., Stolnik, S., & Illum, L. (2009) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2009.06.019 · Cited by 734
The role of lipids in pulmonary surfactant
Veldhuizen, R., Nag, K., Orgeig, S., & Possmayer, F. (1998) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/s0925-4439(98)00061-1 · Cited by 725
Fasano, A., Not, T., Wang, W., Uzzau, S., Berti, I., Tommasini, A., & Goldblum, S. E. (2000) · The Lancet · doi:10.1016/s0140-6736(00)02169-3 · Cited by 670
The Propulsion of Mucus by Cilia
Sleigh, M. A., Blake, J. R., & Liron, N. (1988) · American Review of Respiratory Disease · doi:10.1164/ajrccm/137.3.726 · Cited by 575
Pulmonary surfactant in health and human lung diseases: state of the art
Griese, M. (1999) · European Respiratory Journal · doi:10.1183/09031936.99.13614779 · Cited by 511
Exosomes: Looking back three decades and into the future
Harding, C. V., Heuser, J. E., & Stahl, P. D. (2013) · Journal of Cell Biology · doi:10.1083/jcb.201212113 · Cited by 462
The lung as a route for systemic delivery of therapeutic proteins and peptides
Uchenna Agu, R., Ikechukwu Ugwoke, M., Armand, M., Kinget, R., & Verbeke, N. (2001) · Respiratory Research · doi:10.1186/rr58 · Cited by 411
Ultrafine Particle–Lung Interactions: Does Size Matter?
Kreyling, W. G., Semmler-Behnke, M., & Möller, W. (2006) · Journal of Aerosol Medicine · doi:10.1089/jam.2006.19.74 · Cited by 394
Deli, M. A. (2009) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/j.bbamem.2008.09.016 · Cited by 385
Nasal route and drug delivery systems
Türker, S., Onur, E., & Ózer, Y. (2004) · Pharmacy World & Science · doi:10.1023/b:phar.0000026823.82950.ff · Cited by 354
Schneider, C. S., Xu, Q., Boylan, N. J., Chisholm, J., Tang, B. C., Schuster, B. S., Henning, A., Ensign, L. M., Lee, E., Adstamongkonkul, P., et al. (2017) · Science Advances · doi:10.1126/sciadv.1601556 · Cited by 311
The rise and rise of drug delivery
Rosen, H., & Abribat, T. (2005) · Nature Reviews Drug Discovery · doi:10.1038/nrd1721 · Cited by 296
Absorption-Enhancing Effects of Bile Salts
Moghimipour, E., Ameri, A., & Handali, S. (2015) · Molecules · doi:10.3390/molecules200814451 · Cited by 255
JEON, Y.-J., SHAHIDI, F., & KIM, S.-K. (2000) · Food Reviews International · doi:10.1081/fri-100100286 · Cited by 243
Role of airway surface liquid and submucosal glands in cystic fibrosis lung disease
Verkman, A. S., Song, Y., & Thiagarajah, J. R. (2003) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00417.2002 · Cited by 230
Polymers in Mucoadhesive Drug-Delivery Systems: A Brief Note
Roy, S., Pal, K., Anis, A., Pramanik, K., & Prabhakar, B. (2009) · Designed Monomers and Polymers · doi:10.1163/138577209x12478283327236 · Cited by 218
Liu, Z., Jiang, M., Kang, T., Miao, D., Gu, G., Song, Q., Yao, L., Hu, Q., Tu, Y., Pang, Z., et al. (2013) · Biomaterials · doi:10.1016/j.biomaterials.2013.02.003 · Cited by 217
Cell-penetrating peptides for drug delivery across membrane barriers
Foged, C., & Nielsen, H. M. (2008) · Expert Opinion on Drug Delivery · doi:10.1517/17425247.5.1.105 · Cited by 205
Kiss, T., Fenyvesi, F., Bácskay, I., Váradi, J., Fenyvesi, É., Iványi, R., Szente, L., Tósaki, Á., & Vecsernyés, M. (2010) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2010.04.014 · Cited by 203
Post Isolation Modification of Exosomes for Nanomedicine Applications
Hood, J. L. (2016) · Nanomedicine · doi:10.2217/nnm-2016-0102 · Cited by 201
Ujhelyi, Z., Fenyvesi, F., Váradi, J., Fehér, P., Kiss, T., Veszelka, S., Deli, M., Vecsernyés, M., & Bácskay, I. (2012) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2012.07.005 · Cited by 186
Pauletti, G. M., Okumu, F. W., & Borchardt, R. T. (1997) · Pharmaceutical Research · doi:10.1023/a:1012040425146 · Cited by 177
Cyclodextrins: application in different routes of drug administration.
Shimpi, S., Chauhan, B., & Shimpi, P. C. (2005) · PubMed · Cited by 173
Mechanism of polymeric nanoparticle-based drug transport across the blood-brain barrier (bbb).
Kreuter, J. (2013) · Journal of Microencapsulation · doi:10.3109/02652048.2012.692491 · Cited by 172
Cell-Penetrating Peptides to Enhance Delivery of Oligonucleotide-Based Therapeutics
McClorey, G., & Banerjee, S. (2018) · Biomedicines · doi:10.3390/biomedicines6020051 · Cited by 160
Dendrimers as a Carrier for Pulmonary Delivery of Enoxaparin, a Low-Molecular Weight Heparin
Bai, S., Thomas, C., & Ahsan, F. (2007) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.20849 · Cited by 158
Application of bile acids in drug formulation and delivery
Đanić, M., Pavlović, N., Goločorbin-Kon, S., & Mikov, M. (2013) · Frontiers in Life Science · doi:10.1080/21553769.2013.879925 · Cited by 154
Porter, A. E., Müller, K. H., Skepper, J. N., Midgley, P. A., & Welland, M. E. (2006) · Acta Biomaterialia · doi:10.1016/j.actbio.2006.02.006 · Cited by 151
Marttin, E., Verhoef, J. C., & Merkus, F. W. H. M. (1998) · Journal of drug targeting · doi:10.3109/10611869808997878 · Cited by 147
Liposomes and Micro/Nanoparticles as Colloidal Carriers for Nasal Drug Delivery
Mainardes, R. M., Urban, M. C. C., Cinto, P. O., Chaud, M. V., Evangelista, R. C., & Gremião, M. P. D. (2006) · Current Drug Delivery · doi:10.2174/156720106777731019 · Cited by 136
Zhang, J., Zhu, X. D., Jin, Y., Shan, W., & Huang, Y. (2014) · Molecular Pharmaceutics · doi:10.1021/mp400685v · Cited by 136
Cystic fibrosis: the mechanisms of pathogenesis of an inherited lung disorder
Clunes, M. T., & Boucher, R. C. (2007) · Drug Discovery Today Disease Mechanisms · doi:10.1016/j.ddmec.2007.09.001 · Cited by 134
Curcumin-primed exosomes mitigate endothelial cell dysfunction during hyperhomocysteinemia
Kalani, A., Kamat, P., Chaturvedi, P., Tyagi, S. C., & Tyagi, N. (2014) · Life Sciences · doi:10.1016/j.lfs.2014.04.018 · Cited by 123
Nanotechnology-mediated nose to brain drug delivery for Parkinson's disease: a mini review
Kulkarni, A. D., Vanjari, Y. H., Sancheti, K. H., Belgamwar, V. S., Surana, S. J., & Pardeshi, C. V. (2015) · Journal of drug targeting · doi:10.3109/1061186x.2015.1020809 · Cited by 120
Fan, Y., Chen, M., Zhang, J., Maincent, P., Xia, X., & Wu, W. (2018) · Critical Reviews in Therapeutic Drug Carrier Systems · doi:10.1615/critrevtherdrugcarriersyst.2018024697 · Cited by 115
Phospholipid based colloidal poloxamer–nanocubic vesicles for brain targeting via the nasal route
Ha, S., Mahmoud, A. A. K., Kamel, A. O., Hady, M. A., & Awad, G. A. S. (2012) · Colloids and Surfaces B Biointerfaces · doi:10.1016/j.colsurfb.2012.05.010 · Cited by 114
Neutrophil Elastase Mediates Innate Host Protection against Pseudomonas aeruginosa
Hirche, T. O., Benabid, R., Deslée, G., Gangloff, S. C., Achilefu, S., Guenounou, M., Lebargy, F., Hancock, R. E. W., & Belaaouaj, A. (2008) · The Journal of Immunology · doi:10.4049/jimmunol.181.7.4945 · Cited by 110
Intratracheal delivery of insulin Absorption from solution and aerosol by rat lung
Okumura, K., Iwakawa, S., Yoshida, T., Seki, T., & Komada, F. (1992) · International Journal of Pharmaceutics · doi:10.1016/0378-5173(92)90304-k · Cited by 104
Aerosolized liposomes with dipalmitoyl phosphatidylcholine enhance pulmonary insulin delivery
Chono, S., Fukuchi, R., Seki, T., & Morimoto, K. (2009) · Journal of Controlled Release · doi:10.1016/j.jconrel.2009.03.019 · Cited by 100
In vitro toxicity and permeation of cyclodextrins in Calu-3 cells
Matilainen, L., Toropainen, T., Vihola, H., Hirvonen, J. J., Järvinen, T., Jarho, P., & Järvinen, K. (2007) · Journal of Controlled Release · doi:10.1016/j.jconrel.2007.11.003 · Cited by 95
Delacourt, C., Hérigault, S., Delclaux, C., Poncin, A., Levame, M., HARF, A., Saudubray, F., & Lafuma, C. (2002) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/ajrcmb.26.3.4611 · Cited by 92
Thwala, L. N., Véronique Préat, A., & Csaba, N. (2016) · Expert Opinion on Drug Delivery · doi:10.1080/17425247.2016.1206074 · Cited by 90
Kobayashi, S., Kondo, S., & Juni, K. (1994) · Pharmaceutical Research · doi:10.1023/a:1018926007902 · Cited by 87
Murata, M., Nakano, K., Tahara, K., Tozuka, Y., & Takeuchi, H. (2011) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2011.10.011 · Cited by 87
Gopalakrishnan, S., PANDEY, N., Tamiz, A. P., Vere, J., CARRASCO, R., Somerville, R. P. T., TRIPATHI, A., Ginski, M. J., Paterson, B. F., & Alkan, Ş. Ş. (2008) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2008.08.047 · Cited by 87
Inapagolla, R., Guru, B. R., Kurtoglu, Y. E., Gao, X., Lieh-Lai, M. W., Bassett, D. J. P., & Kannan, R. M. (2010) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2010.07.030 · Cited by 85
A claudin-4 modulator enhances the mucosal absorption of a biologically active peptide
Uchida, H., Kondoh, M., Hanada, T., Takahashi, A., Hamakubo, T., & Yagi, K. (2010) · Biochemical Pharmacology · doi:10.1016/j.bcp.2010.01.010 · Cited by 78
Róka, E., Ujhelyi, Z., Deli, M. A., Bocsik, A., Fenyvesi, É., Szente, L., Fenyvesi, F., Vecsernyés, M., Váradi, J., Fehér, P. S., et al. (2015) · Molecules · doi:10.3390/molecules201119694 · Cited by 74
Helms, H. C. C., Waagepetersen, H. S., Nielsen, C. U., & Brodin, B. (2010) · The AAPS Journal · doi:10.1208/s12248-010-9237-6 · Cited by 73
Vecchio, G. D., Tscheik, C., Tenz, K., Helms, H. C. C., Winkler, L., Blasig, R., & Blasig, I. E. (2012) · Molecular Pharmaceutics · doi:10.1021/mp3001414 · Cited by 70
Salem, L. B., Bosquillon, C., Dailey, L. A., Delattre, L., Martin, G. P., Évrard, B., & Forbes, B. (2009) · Journal of Controlled Release · doi:10.1016/j.jconrel.2009.01.019 · Cited by 69
Manca, M. L., Peris, J., Melis, V., Valenti, D., Cardia, M. C., Lattuada, D., Escribano‐Ferrer, E., Fadda, A. M., & Manconi, M. (2015) · RSC Advances · doi:10.1039/c5ra24032h · Cited by 67
Shubber, S., Vllasaliu, D., Rauch, C., Jordan, F., Illum, L., & Stolnik, S. (2014) · Pharmaceutical Research · doi:10.1007/s11095-014-1481-5 · Cited by 63
Plasmid DNA delivery by arginine-rich cell-penetrating peptides containing unnatural amino acids
Kato, T., Yamashita, H., Misawa, T., Nishida, K., Kurihara, M., Tanaka, M., Demizu, Y., & Oba, M. (2016) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2016.04.031 · Cited by 63
Phospholipids in pulmonary drug delivery
Wauthoz, N., & Amighi, K. (2014) · European Journal of Lipid Science and Technology · doi:10.1002/ejlt.201300368 · Cited by 62
Inhalable polymer-glycerosomes as safe and effective carriers for rifampicin delivery to the lungs
Melis, V., Manca, M. L., Bullita, E., Tamburini, E., Castangia, I., Cardia, M. C., Valenti, D., Fadda, A. M., Peris, J., & Manconi, M. (2016) · Colloids and Surfaces B Biointerfaces · doi:10.1016/j.colsurfb.2016.03.044 · Cited by 60
Zhang, X., Lin, C., Lü, A., Lin, G., Chen, H., Liu, Q., Yang, Z., & Zhang, H. (2017) · Drug Delivery · doi:10.1080/10717544.2017.1340361 · Cited by 58
Kamei, N., Tanaka, M., Choi, H., Okada, N., Ikeda, T., Itokazu, R., & Takeda‐Morishita, M. (2017) · Molecular Pharmaceutics · doi:10.1021/acs.molpharmaceut.6b01134 · Cited by 53
Smedley, J. G., Saputo, J., Parker, J. C., Fernández-Miyakawa, M. E., Robertson, S. L., McClane, B. A., & Uzal, F. A. (2008) · Infection and Immunity · doi:10.1128/iai.00460-08 · Cited by 52
Na, L., Mao, S., Wang, J., & Sun, W. (2010) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2010.06.048 · Cited by 52
Sonia, T. A., Rekha, M. R., & Sharma, C. P. (2010) · Journal of Applied Polymer Science · doi:10.1002/app.32979 · Cited by 51
Karasulu, E., Yavaşoğlu, A., Evrenşanal, Z., Uyanıkgil, Y., & Karasulu, H. Y. (2008) · Drug Delivery · doi:10.1080/10717540802006377 · Cited by 50
Phospholipid complex as an approach for bioavailability enhancement of echinacoside
Li, F., Yang, X., Yang, Y., Li, P., Yang, Z., & Zhang, C. (2015) · Drug Development and Industrial Pharmacy · doi:10.3109/03639045.2015.1004183 · Cited by 49
Benediktsdóttir, B. E., Guðjónsson, Þ., Baldursson, Ó., & Másson, M. (2013) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2013.04.002 · Cited by 49
Chen, K. H., Sabatino, M. D., Albertini, B., Passerini, N., & Kett, V. L. (2013) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2013.07.006 · Cited by 47
High efficiency intranasal drug delivery using Intravail® alkylsaccharide absorption enhancers
Maggio, E., & Pillion, D. J. (2012) · Drug Delivery and Translational Research · doi:10.1007/s13346-012-0069-z · Cited by 47
Improving oral drug bioavailability with polycations?
Schulz, J. D., Gauthier, M. A., & Leroux, J. (2015) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2015.04.025 · Cited by 47
Effect of Hydrophobic Surfactant Proteins SP-B and SP-C on Binary Phospholipid Monolayers
Brockman, J. M., Wang, Z., Notter, R. H., et al. (2003) · Biophysical Journal · doi:10.1016/s0006-3495(03)74853-x · Cited by 45
Absorption enhancers in nasal insulin delivery and their influence on nasal ciliary functioning
Schipper, N. G. M., Verhoef, J., Romeijn, S. G., & Merkus, F. W. H. M. (1992) · Journal of Controlled Release · doi:10.1016/0168-3659(92)90019-n · Cited by 44
Hydrophobically modified chitosan nanoliposomes for intestinal drug delivery
Zariwala, M. G., Bendre, H., Markiv, A., Farnaud, S., Renshaw, D. W., Taylor, K. M. G., & Somavarapu, S. (2018) · International Journal of Nanomedicine · doi:10.2147/ijn.s166901 · Cited by 42
Claudin-1 Binder Enhances Epidermal Permeability in a Human Keratinocyte Model
Nakajima, M., Nagase, S., Iida, M., Takeda, S., Yamashita, M., Watari, A., Shirasago, Y., Fukasawa, M., Takeda, H., Sawasaki, T., et al. (2015) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.115.225391 · Cited by 38
Acute Mechanism of Medium Chain Fatty Acid-Induced Enhancement of Airway Epithelial Permeability
Coyne, C. B., Ribeiro, C. M. P., Boucher, R. C., & Johnson, L. G. (2003) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.102.047654 · Cited by 36
Inoue, D., Tanaka, A., Kimura, S., Kiriyama, A., Katsumi, H., Yamamoto, A., Ogawara, K., Kimura, T., Higaki, K., Yutani, R., et al. (2018) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2018.01.032 · Cited by 36
Gibbons, A., McElvaney, N. G., & Cryan, S. (2010) · AAPS PharmSciTech · doi:10.1208/s12249-010-9500-2 · Cited by 35
The influence of absorption enhancers on nasal absorption of acyclovir
Chavanpatil, M. D., & Vavia, P. R. (2004) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2004.01.001 · Cited by 35
Bile salt enhancers for inhalation: Correlation between in vitro and in vivo lung effects
Sørli, J. B., Sivars, K. B., Silva, E. D., Hougaard, K. S., Koponen, I. K., Zuo, Y. Y., Weydahl, I. E. K., Åberg, P. M., & Fransson, R. (2018) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2018.08.031 · Cited by 35
The use of fatty acids as absorption enhancer for pulmonary drug delivery
Ghadiri, M., Canney, F., Pacciana, C., Colombo, G., Young, P. M., & Traini, D. (2018) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2018.02.027 · Cited by 34
Self-citationRecent progress in tight junction modulation for improving bioavailability
Saaber, D., Wollenhaupt, S., Baumann, K., & Reichl, S. (2014) · Expert Opinion on Drug Discovery · doi:10.1517/17460441.2014.892070 · Cited by 26
Effect of Rhamnolipids on Permeability Across Caco-2 Cell Monolayers
Wallace, C. J., Medina, S. H., & ElSayed, M. E. H. (2013) · Pharmaceutical Research · doi:10.1007/s11095-013-1210-5 · Cited by 25
Rhamnolipids as epithelial permeability enhancers for macromolecular therapeutics
Perinelli, D. R., Vllasaliu, D., Bonacucina, G., Come, B., Pucciarelli, S., Ricciutelli, M., Cespi, M., Itri, R., Spinozzi, F., Palmieri, G. F., et al. (2017) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2017.07.011 · Cited by 22
Zheng, J., Zheng, Y., Chen, J., Fang, F., He, J., Li, N., Tang, Y., Zhu, J., & Chen, X. (2012) · Die Pharmazie · doi:10.31083/ph.2012.1132 · Cited by 20
Effect of polyunsaturated fatty acids (PUFAs) on airway epithelial cells' tight junction
Ghadiri, M., Mamlouk, M., Spicer, P. T., Jarolimek, W., Grau, G. E., Young, P. M., & Traini, D. (2016) · Pulmonary Pharmacology & Therapeutics · doi:10.1016/j.pupt.2016.07.004 · Cited by 20
Self-citationAmancha, K. P., & Hussain, A. (2014) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2014.11.008 · Cited by 18
Structure–activity relationship studies of permeability modulating peptide AT-1002
Li, M., Oliver, E. J., Kitchens, K. M., Vere, J., Alkan, Ş. Ş., & Tamiz, A. P. (2008) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2008.07.028 · Cited by 18
Epithelial Toxicity of Alkylglycoside Surfactants
Vllasaliu, D., Shubber, S., Fowler, R., Garnett, M. C., Alexander, C., & Stolnik, S. (2012) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.23340 · Cited by 18
Basabe-Burgos, O., Ahlström, J. Z., Stichtenoth, G., Curstedt, T., Bergman, P., Johansson, J., & Rising, A. (2018) · Journal of Aerosol Medicine and Pulmonary Drug Delivery · doi:10.1089/jamp.2018.1468 · Cited by 17
Kamei, N. (2017) · YAKUGAKU ZASSHI · doi:10.1248/yakushi.17-00138 · Cited by 15
Zheng, J., Zhang, G., Lu, Y., Fang, F., He, J., Li, N., Talbi, A., Zhang, Y., Tang, Y., Zhu, J., et al. (2010) · Chemical and Pharmaceutical Bulletin · doi:10.1248/cpb.58.1612 · Cited by 12
Cited by
Intranasal drug delivery: opportunities and toxicologic challenges during drug development
Keller, L.-A., Merkel, O., & Popp, A. (2022) · Drug Delivery and Translational Research · doi:10.1007/s13346-020-00891-5 · Cited by 591
Advances in Nanotechnology for Enhancing the Solubility and Bioavailability of Poorly Soluble Drugs
Liu, Y., Liang, Y., Yuhong, J., Xin, P., Han, J. L., Du, Y., Yu, X., Zhu, R., Zhang, M., Chen, W., et al. (2024) · Drug Design, Development and Therapy · doi:10.2147/dddt.s447496 · Cited by 365
Khatri, D. K., Preeti, K., Tonape, S., Bhattacharjee, S., Patel, M., Shah, S., Singh, P. K., Srivastava, S., Gugulothu, D., Vora, L., et al. (2023) · Current Neuropharmacology · doi:10.2174/1570159x20666220507022701 · Cited by 75
Intranasal Drug Administration in Alzheimer-Type Dementia: Towards Clinical Applications
Taléns-Visconti, R., de Julián-Ortiz, J. V., Vila-Busó, O., Diez-Sales, O., & Nácher, A. (2023) · Pharmaceutics · doi:10.3390/pharmaceutics15051399 · Cited by 59
Aati, S., Farouk, H. O., Elkarmalawy, M. H., Aati, H. Y., Tolba, N. S., Hassan, H. M., Rateb, M. E., & Hamad, D. S. (2024) · Pharmaceutics · doi:10.3390/pharmaceutics16111432 · Cited by 9
Metadata
- Authors
- Ghadiri, M., Young, P. M., & Traini, D.
- Venue
- Pharmaceutics
- Publisher
- MDPI AG
- Published
- 2019-03-11
- Volume
- 11
- Issue
- 3
- Pages
- 113
- ISSN
- 1999-4923 (ISSN-L)
- OpenAlex
- W2921248422
- Cited by
- 284
- References
- 97
- FWCI
- 10.99
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.